Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.83 USD | +0.63% | -1.80% | -18.84% |
02:31pm | Barclays Adjusts Price Target on Gilead Sciences to $76 From $80 | MT |
Apr. 26 | TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.84% | 81.58B | |
+26.04% | 661B | |
+26.74% | 566B | |
-6.58% | 352B | |
+18.78% | 332B | |
+3.70% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.25% | 145B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- RBC Cuts Price Target on Gilead Sciences to $76 From $78, Notes Core Business Headwinds, Pipeline Setbacks; Keeps Sector Perform Rating